 Quanbin Xu
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 8 | 2016 | 551 | 1.810 |
Why?
| | Protein-Tyrosine Kinases | 8 | 2016 | 395 | 1.580 |
Why?
| | Spindle Apparatus | 4 | 2014 | 87 | 1.180 |
Why?
| | Kinetochores | 3 | 2013 | 44 | 0.820 |
Why?
| | Transforming Growth Factor alpha | 2 | 2010 | 53 | 0.700 |
Why?
| | ErbB Receptors | 2 | 2010 | 554 | 0.560 |
Why?
| | Colonic Neoplasms | 2 | 2016 | 215 | 0.510 |
Why?
| | Mitosis | 3 | 2016 | 164 | 0.510 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 355 | 0.460 |
Why?
| | Aneuploidy | 1 | 2014 | 85 | 0.450 |
Why?
| | Metaphase | 1 | 2013 | 28 | 0.430 |
Why?
| | M Phase Cell Cycle Checkpoints | 2 | 2016 | 23 | 0.410 |
Why?
| | Cell Line, Tumor | 8 | 2016 | 2711 | 0.380 |
Why?
| | Superantigens | 1 | 2010 | 69 | 0.360 |
Why?
| | Ultraviolet Rays | 1 | 2013 | 363 | 0.350 |
Why?
| | Melanoma, Experimental | 1 | 2010 | 89 | 0.350 |
Why?
| | Enterotoxins | 1 | 2010 | 88 | 0.340 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2015 | 367 | 0.340 |
Why?
| | Blood Pressure | 1 | 2016 | 1538 | 0.340 |
Why?
| | Cell Division | 1 | 2011 | 758 | 0.330 |
Why?
| | Signal Transduction | 7 | 2016 | 4516 | 0.330 |
Why?
| | Epidermal Growth Factor | 1 | 2010 | 161 | 0.330 |
Why?
| | Cancer Vaccines | 1 | 2010 | 137 | 0.310 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 388 | 0.310 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 535 | 0.280 |
Why?
| | Immunotherapy | 1 | 2010 | 474 | 0.280 |
Why?
| | Thiazoles | 2 | 2018 | 110 | 0.240 |
Why?
| | Brain | 1 | 2016 | 2371 | 0.240 |
Why?
| | Ubiquitination | 2 | 2015 | 86 | 0.230 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2015 | 110 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 616 | 0.210 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 197 | 0.210 |
Why?
| | Phosphorylation | 6 | 2014 | 1569 | 0.200 |
Why?
| | Gene Editing | 1 | 2020 | 57 | 0.170 |
Why?
| | Gene Transfer Techniques | 1 | 2020 | 147 | 0.170 |
Why?
| | Down-Regulation | 2 | 2014 | 594 | 0.170 |
Why?
| | Exosomes | 1 | 2020 | 92 | 0.170 |
Why?
| | HEK293 Cells | 3 | 2020 | 591 | 0.170 |
Why?
| | Depsipeptides | 1 | 2018 | 13 | 0.150 |
Why?
| | TNF Receptor-Associated Factor 3 | 2 | 2015 | 5 | 0.150 |
Why?
| | Histone Code | 1 | 2018 | 28 | 0.150 |
Why?
| | Voltage-Dependent Anion Channel 1 | 2 | 2016 | 9 | 0.140 |
Why?
| | Protein Structure, Tertiary | 3 | 2015 | 796 | 0.140 |
Why?
| | Amino Acid Sequence | 3 | 2010 | 1982 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2018 | 151 | 0.140 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2018 | 198 | 0.130 |
Why?
| | Renin | 1 | 2016 | 31 | 0.130 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2785 | 0.130 |
Why?
| | Animals | 10 | 2020 | 31709 | 0.130 |
Why?
| | Immunity, Innate | 4 | 2014 | 720 | 0.130 |
Why?
| | Angiotensin II | 1 | 2016 | 87 | 0.130 |
Why?
| | Cell Line | 5 | 2018 | 2637 | 0.130 |
Why?
| | Renin-Angiotensin System | 1 | 2016 | 72 | 0.130 |
Why?
| | Protein Binding | 3 | 2016 | 1890 | 0.120 |
Why?
| | Interphase | 1 | 2015 | 32 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 4694 | 0.120 |
Why?
| | Karyopherins | 1 | 2015 | 15 | 0.120 |
Why?
| | Humans | 16 | 2020 | 114709 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2015 | 84 | 0.120 |
Why?
| | Oligopeptides | 1 | 2016 | 236 | 0.120 |
Why?
| | Enterovirus A, Human | 1 | 2014 | 12 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 171 | 0.120 |
Why?
| | Cytoplasm | 1 | 2015 | 255 | 0.110 |
Why?
| | Immune Evasion | 1 | 2014 | 47 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 325 | 0.110 |
Why?
| | DEAD-box RNA Helicases | 1 | 2014 | 56 | 0.110 |
Why?
| | Inflammasomes | 1 | 2015 | 115 | 0.110 |
Why?
| | RNA Interference | 2 | 2015 | 433 | 0.110 |
Why?
| | Protein Transport | 1 | 2015 | 395 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 192 | 0.110 |
Why?
| | Mice | 7 | 2020 | 14872 | 0.110 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 19 | 0.110 |
Why?
| | Tamoxifen | 1 | 2014 | 191 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2016 | 429 | 0.100 |
Why?
| | Caspase 3 | 1 | 2013 | 235 | 0.100 |
Why?
| | Viral Proteins | 1 | 2014 | 281 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 397 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2016 | 666 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2015 | 554 | 0.100 |
Why?
| | G2 Phase | 1 | 2011 | 31 | 0.100 |
Why?
| | Tyrosine | 1 | 2012 | 214 | 0.100 |
Why?
| | Chromosome Segregation | 1 | 2011 | 36 | 0.090 |
Why?
| | Mitochondria | 1 | 2016 | 747 | 0.090 |
Why?
| | G1 Phase | 1 | 2010 | 68 | 0.090 |
Why?
| | Quinolines | 1 | 2011 | 129 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1147 | 0.090 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2009 | 13 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 638 | 0.080 |
Why?
| | Interferon-beta | 1 | 2009 | 79 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 335 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 850 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2009 | 133 | 0.080 |
Why?
| | Mad2 Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| | Spleen | 1 | 2010 | 487 | 0.080 |
Why?
| | MicroRNAs | 1 | 2014 | 600 | 0.080 |
Why?
| | Hypertension | 1 | 2016 | 1056 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2009 | 219 | 0.070 |
Why?
| | Immunization | 1 | 2010 | 397 | 0.070 |
Why?
| | Apoptosis | 2 | 2013 | 2363 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 206 | 0.070 |
Why?
| | Escherichia coli | 1 | 2010 | 720 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2008 | 366 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 562 | 0.060 |
Why?
| | Vesiculovirus | 2 | 2013 | 9 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2014 | 1862 | 0.050 |
Why?
| | Vesicular Stomatitis | 2 | 2013 | 3 | 0.050 |
Why?
| | Host-Pathogen Interactions | 2 | 2014 | 295 | 0.050 |
Why?
| | Argonaute Proteins | 1 | 2020 | 28 | 0.050 |
Why?
| | Caspase 9 | 1 | 2020 | 48 | 0.050 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 41 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 73 | 0.040 |
Why?
| | Integrases | 1 | 2020 | 116 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 282 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 371 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 430 | 0.040 |
Why?
| | Cytostatic Agents | 1 | 2018 | 6 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2010 | 785 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1144 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2015 | 2570 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 133 | 0.040 |
Why?
| | Oncogenes | 1 | 2018 | 103 | 0.040 |
Why?
| | Acetylation | 1 | 2018 | 211 | 0.040 |
Why?
| | Polyploidy | 1 | 2016 | 16 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2018 | 195 | 0.030 |
Why?
| | Cytokinesis | 1 | 2016 | 46 | 0.030 |
Why?
| | Genome | 1 | 2018 | 271 | 0.030 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 17 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2018 | 284 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 151 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 323 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 7 | 0.030 |
Why?
| | DEAD Box Protein 58 | 1 | 2014 | 8 | 0.030 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2014 | 14 | 0.030 |
Why?
| | Immunoblotting | 1 | 2015 | 283 | 0.030 |
Why?
| | Vero Cells | 1 | 2014 | 63 | 0.030 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 60 | 0.030 |
Why?
| | Phosphoserine | 1 | 2014 | 33 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2014 | 61 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1842 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1131 | 0.030 |
Why?
| | Interferon Type I | 1 | 2014 | 128 | 0.030 |
Why?
| | Dogs | 1 | 2014 | 334 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 396 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 34 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2014 | 201 | 0.030 |
Why?
| | Histones | 1 | 2018 | 535 | 0.030 |
Why?
| | Cell Survival | 1 | 2016 | 1021 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1637 | 0.030 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 121 | 0.030 |
Why?
| | Virus Diseases | 1 | 2015 | 195 | 0.030 |
Why?
| | Protein Stability | 1 | 2013 | 157 | 0.030 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2012 | 3 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2013 | 157 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 395 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 811 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2553 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 808 | 0.020 |
Why?
| | Catalysis | 1 | 2010 | 289 | 0.020 |
Why?
| | Mutation | 2 | 2010 | 3346 | 0.020 |
Why?
| | Fibroblasts | 1 | 2013 | 838 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2009 | 352 | 0.020 |
Why?
| | Protein Subunits | 1 | 2009 | 201 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1313 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1263 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1230 | 0.020 |
Why?
| | Protein Conformation | 1 | 2009 | 805 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2320 | 0.020 |
Why?
| | Models, Molecular | 1 | 2009 | 1369 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2009 | 1019 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 3886 | 0.010 |
Why?
| | Female | 2 | 2020 | 59523 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 9088 | 0.010 |
Why?
|
|
Xu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|